Explainer · August 2, 2026 · 4 min · By Tariq Mehmood
Silent Rupture: The Implant Screening Schedule Most Los Angeles Patients Never Hear About
Silicone implants can fail without symptoms, and federal guidance now calls for imaging years before most patients think to ask. Here is what the screening timeline looks like, why rupture is often invisible, and what the scans can and cannot tell you.
Los Angeles performs more breast augmentations per capita than almost any market in the country, which means it also has one of the largest populations of people living with implants that are five, ten, or twenty years old. What many of those patients do not know is that silicone gel implants carry a formal imaging schedule, and that a rupture can exist for years without producing a single symptom. This is not a scare point. It is a maintenance point, the same way a car has service intervals whether or not the dashboard light comes on.
Why silicone rupture is silent. A saline implant that fails announces itself. The shell tears, the salt water is absorbed by the body within days, and the breast visibly deflates. Silicone behaves differently. Modern gel is cohesive, meaning the molecules are cross linked enough that the material holds its shape rather than flowing freely. When the shell of a cohesive implant tears, the gel often stays inside the scar capsule your body built around the device. The breast can look and feel completely normal. Surgeons call this an intracapsular rupture, and it is the most common failure pattern. Because there is no deflation, no pain in most cases, and no visible change, physical examination misses the majority of these events. That is the entire rationale for imaging.
What the current guidance actually says. In 2020 the FDA updated its screening recommendations for silicone gel implants. The current advice is to have either an MRI or an ultrasound at five to six years after placement, even with no symptoms, and then repeat imaging every two to three years after that. If you develop symptoms at any point, such as new firmness, a change in shape, swelling, or pain, imaging is recommended right away regardless of where you are in the cycle. The earlier guidance had recommended MRI starting at three years, and the shift to five to six years with ultrasound as an accepted first option reflected both device durability data and the practical reality that almost no one was complying with the old schedule.
MRI versus ultrasound, in plain terms. MRI is the more sensitive study. It can detect the classic internal signs of shell collapse, including what radiologists call the linguine sign, where the folded shell floats inside the gel. Sensitivity for rupture on MRI is generally reported above 90 percent. The trade offs are cost, since screening MRI for implants is rarely covered by insurance and in the Los Angeles market typically runs several hundred to over a thousand dollars, and access, since it requires a dedicated breast coil and a facility comfortable reading implant protocols. Ultrasound is cheaper, faster, and widely available, and in experienced hands it detects most intracapsular ruptures through findings like the stepladder sign. Its weakness is operator dependence. A technician who rarely scans implants can miss what a high volume breast imaging center would catch. A reasonable strategy many surgeons endorse is ultrasound first, with MRI reserved for equivocal results or ongoing symptoms despite a normal ultrasound.
What screening does not do. Imaging tells you the structural status of the shell. It does not screen for breast cancer, so routine mammography continues on its normal schedule, with the technologist informed about the implants so displacement views can be used. Implant imaging also does not evaluate capsular contracture, which is a clinical diagnosis based on firmness and shape, not a radiologic one. And a normal scan is a snapshot, not a warranty. Rupture risk rises with device age, which is why the interval repeats rather than ending.
Does a silent rupture need surgery immediately? This is the question patients ask most, and the honest answer is that it depends on whether the gel has stayed inside the capsule. An intracapsular rupture in an asymptomatic patient is generally treated as a reason to plan removal or exchange on a reasonable timeline, not an emergency. If gel has migrated outside the capsule, called extracapsular rupture, most surgeons recommend more prompt removal because free silicone can cause inflammation and granulomas in surrounding tissue and becomes harder to retrieve over time.
The practical takeaway for LA patients. If your silicone implants are past the five year mark and you have never had them imaged, you are not alone, and you are not in crisis. But you are overdue by current federal guidance. Ask where your surgeon refers for implant protocol ultrasound or MRI, keep your device card with the manufacturer, style, and serial number where you can find it, and treat imaging as scheduled maintenance. Implants are medical devices with a service life. The screening schedule exists so that when one quietly reaches the end of that life, you find out from a scan instead of a complication.
Related reading: Why 350cc Means Different Things on Different Chests: A Sizing Explainer for Los Angeles Patients.